Kevin Claffey - Publications

Affiliations: 
University of Connecticut, Storrs, CT, United States 
Area:
Cell Biology, Oncology

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Devarakonda CV, Kita D, Phoenix KN, Claffey KP. Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors. Bmc Cancer. 15: 614. PMID 26334999 DOI: 10.1186/s12885-015-1608-z  0.92
2015 Wang Y, Cao Y, Yamada S, Thirunavukkarasu M, Nin V, Joshi M, Rishi MT, Bhattacharya S, Camacho-Pereira J, Sharma AK, Shameer K, Kocher JP, Sanchez JA, Wang E, Hoeppner LH, ... ... Claffey KP, et al. Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-α Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1α and Mitochondrial Homeostasis. Arteriosclerosis, Thrombosis, and Vascular Biology. 35: 1401-12. PMID 25882068 DOI: 10.1161/ATVBAHA.115.305566  0.36
2015 Choudhary D, Hegde P, Voznesensky O, Choudhary S, Kopsiaftis S, Claffey KP, Pilbeam CC, Taylor JA. Increased expression of L-selectin (CD62L) in high-grade urothelial carcinoma: A potential marker for metastatic disease. Urologic Oncology. PMID 25618296 DOI: 10.1016/j.urolonc.2014.12.009  0.36
2014 Hutchins-Wiese HL, Picho K, Watkins BA, Li Y, Tannenbaum S, Claffey K, Kenny AM. High-dose eicosapentaenoic acid and docosahexaenoic acid supplementation reduces bone resorption in postmenopausal breast cancer survivors on aromatase inhibitors: a pilot study. Nutrition and Cancer. 66: 68-76. PMID 24274259 DOI: 10.1080/01635581.2014.847964  0.36
2013 Fox MM, Phoenix KN, Kopsiaftis SG, Claffey KP. AMP-Activated Protein Kinase α 2 Isoform Suppression in Primary Breast Cancer Alters AMPK Growth Control and Apoptotic Signaling. Genes & Cancer. 4: 3-14. PMID 23946867 DOI: 10.1177/1947601913486346  0.92
2012 Phoenix KN, Devarakonda CV, Fox MM, Stevens LE, Claffey KP. AMPKα2 Suppresses Murine Embryonic Fibroblast Transformation and Tumorigenesis. Genes & Cancer. 3: 51-62. PMID 22893790 DOI: 10.1177/1947601912452883  0.92
2012 Hoeppner LH, Phoenix KN, Clark KJ, Bhattacharya R, Gong X, Sciuto TE, Vohra P, Suresh S, Bhattacharya S, Dvorak AM, Ekker SC, Dvorak HF, Claffey KP, Mukhopadhyay D. Revealing the role of phospholipase Cβ3 in the regulation of VEGF-induced vascular permeability. Blood. 120: 2167-73. PMID 22674805 DOI: 10.1182/blood-2012-03-417824  0.36
2011 Biswal NC, Pavlik C, Smith MB, Aguirre A, Xu Y, Zanganeh S, Kuhn LT, Claffey KP, Zhu Q. Imaging tumor hypoxia by near-infrared fluorescence tomography. Journal of Biomedical Optics. 16: 066009. PMID 21721810 DOI: 10.1117/1.3589348  0.36
2010 Phoenix KN, Vumbaca F, Fox MM, Evans R, Claffey KP. Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy. Breast Cancer Research and Treatment. 123: 333-44. PMID 20204498 DOI: 10.1007/s10549-009-0647-z  0.92
2009 Adams BD, Claffey KP, White BA. Argonaute-2 expression is regulated by epidermal growth factor receptor and mitogen-activated protein kinase signaling and correlates with a transformed phenotype in breast cancer cells. Endocrinology. 150: 14-23. PMID 18787018 DOI: 10.1210/en.2008-0984  0.36
2009 Rodriguez-Pinto D, Sparkowski J, Keough MP, Phoenix KN, Vumbaca F, Han DK, Gundelfinger ED, Beesley P, Claffey KP. Identification of novel tumor antigens with patient-derived immune-selected antibodies. Cancer Immunology, Immunotherapy : Cii. 58: 221-34. PMID 18568347 DOI: 10.1007/s00262-008-0543-0  0.36
2009 Phoenix KN, Vumbaca F, Claffey KP. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Research and Treatment. 113: 101-11. PMID 18256928 DOI: 10.1007/s10549-008-9916-5  0.92
2008 Peluso JJ, Liu X, Saunders MM, Claffey KP, Phoenix K. Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1 Journal of Clinical Endocrinology and Metabolism. 93: 1592-1599. PMID 18319313 DOI: 10.1210/jc.2007-2771  0.36
2008 Wang Z, Liu B, Wang P, Dong X, Fernandez-Hernando C, Li Z, Hla T, Li Z, Claffey K, Smith JD, Wu D. Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice. The Journal of Clinical Investigation. 118: 195-204. PMID 18079968 DOI: 10.1172/JCI33139  0.36
2008 Vumbaca F, Phoenix KN, Rodriguez-Pinto D, Han DK, Claffey KP. Double-stranded RNA-binding protein regulates vascular endothelial growth factor mRNA stability, translation, and breast cancer angiogenesis. Molecular and Cellular Biology. 28: 772-83. PMID 18039850 DOI: 10.1128/MCB.02078-06  0.92
2007 Skoura A, Sanchez T, Claffey K, Mandala SM, Proia RL, Hla T. Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. The Journal of Clinical Investigation. 117: 2506-16. PMID 17710232 DOI: 10.1172/JCI31123  0.36
2007 Backer MV, Levashova Z, Patel V, Jehning BT, Claffey K, Blankenberg FG, Backer JM. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes. Nature Medicine. 13: 504-9. PMID 17351626 DOI: 10.1038/nm1522  0.36
2007 Backer MV, Patel V, Jehning BT, Claffey KP, Karginov VA, Backer JM. Inhibition of anthrax protective antigen outside and inside the cell. Antimicrobial Agents and Chemotherapy. 51: 245-51. PMID 17074791 DOI: 10.1128/AAC.00983-06  0.36
2006 Backer MV, Patel V, Jehning BT, Claffey KP, Backer JM. Surface immobilization of active vascular endothelial growth factor via a cysteine-containing tag. Biomaterials. 27: 5452-8. PMID 16843524 DOI: 10.1016/j.biomaterials.2006.06.025  0.36
2006 Neurath KM, Keough MP, Mikkelsen T, Claffey KP. AMP-dependent protein kinase alpha 2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma. Glia. 53: 733-43. PMID 16518831 DOI: 10.1002/glia.20326  0.36
2006 Muñoz-Nájar UM, Neurath KM, Vumbaca F, Claffey KP. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene. 25: 2379-92. PMID 16369494 DOI: 10.1038/sj.onc.1209273  0.52
2005 Backer MV, Gaynutdinov TI, Patel V, Bandyopadhyaya AK, Thirumamagal BT, Tjarks W, Barth RF, Claffey K, Backer JM. Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature. Molecular Cancer Therapeutics. 4: 1423-9. PMID 16170035 DOI: 10.1158/1535-7163.MCT-05-0161  0.36
2005 Bhisitkul RB, Robinson GS, Moulton RS, Claffey KP, Gragoudas ES, Miller JW. An antisense oligodeoxynucleotide against vascular endothelial growth factor in a nonhuman primate model of iris neovascularization Archives of Ophthalmology. 123: 214-219. PMID 15710818 DOI: 10.1001/archopht.123.2.214  0.36
2004 Kluk MJ, Grant-Kels JM, Kerr P, Hoss D, Berke A, Claffey KP, Murphy M. Melanoma on the move: the progression of melanoma: novel concepts with histologic correlates. The American Journal of Dermatopathology. 26: 504-10. PMID 15618934 DOI: 10.1097/00000372-200412000-00011  0.36
2004 Murphy M, Carlson JA, Keough MP, Claffey KP, Signoretti S, Loda M. Hypoxia regulation of the cell cycle in malignant melanoma: putative role for the cyclin-dependent kinase inhibitor p27. Journal of Cutaneous Pathology. 31: 477-82. PMID 15239677 DOI: 10.1111/j.0303-6987.2004.00205.x  0.36
2003 Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, Brinkmann V, Claffey K, Hla T. Phosphorylation and action of the immunomodulator FTY720 inhibits vascular endothelial cell growth factor-induced vascular permeability. The Journal of Biological Chemistry. 278: 47281-90. PMID 12954648 DOI: 10.1074/jbc.M306896200  0.36
2003 Jang BC, Muñoz-Najar U, Paik JH, Claffey K, Yoshida M, Hla T. Leptomycin B, an inhibitor of the nuclear export receptor CRM1, inhibits COX-2 expression. The Journal of Biological Chemistry. 278: 2773-6. PMID 12468543 DOI: 10.1074/jbc.C200620200  0.36
Show low-probability matches.